ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 56 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $134,002 | +24.6% | 84,278 | -43.8% | 0.00% | 0.0% |
Q1 2023 | $107,507 | -7.5% | 149,856 | -25.3% | 0.00% | 0.0% |
Q4 2022 | $116,183 | -40.1% | 200,489 | -1.6% | 0.00% | 0.0% |
Q3 2022 | $194,000 | +37.6% | 203,725 | +73.4% | 0.00% | 0.0% |
Q2 2022 | $141,000 | -64.5% | 117,512 | -61.2% | 0.00% | -50.0% |
Q1 2022 | $397,000 | -33.4% | 302,717 | -10.6% | 0.00% | -33.3% |
Q4 2021 | $596,000 | -25.4% | 338,740 | -8.1% | 0.00% | -25.0% |
Q3 2021 | $799,000 | +111.9% | 368,405 | +411.5% | 0.00% | +100.0% |
Q1 2019 | $377,000 | +35.6% | 72,025 | -18.5% | 0.00% | 0.0% |
Q4 2018 | $278,000 | -70.7% | 88,325 | -43.6% | 0.00% | -60.0% |
Q3 2018 | $948,000 | +10.6% | 156,650 | -3.1% | 0.01% | 0.0% |
Q2 2018 | $857,000 | -14.0% | 161,650 | -5.9% | 0.01% | -16.7% |
Q1 2018 | $996,000 | +45.6% | 171,750 | -12.2% | 0.01% | +50.0% |
Q4 2017 | $684,000 | -18.1% | 195,550 | -14.5% | 0.00% | -20.0% |
Q3 2017 | $835,000 | +45.7% | 228,750 | -0.3% | 0.01% | +25.0% |
Q2 2017 | $573,000 | -7.4% | 229,350 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $619,000 | -7.3% | 229,350 | -0.4% | 0.00% | -20.0% |
Q4 2016 | $668,000 | -38.0% | 230,350 | -12.2% | 0.01% | -37.5% |
Q3 2016 | $1,078,000 | +12.8% | 262,250 | -13.3% | 0.01% | +14.3% |
Q2 2016 | $956,000 | – | 302,450 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |